McKinsey Opened a Door in Its Firewall Between Pharma Clients and Regulators
The firm let consultants advise both drugmakers and their government overseers, internal records show. “Who we know and what we know” was part of their pitch.
View original article
Contributor: Chris Hamby, Walt Bogdanich, Michael Forsythe and Jennifer Valentino-DeVries
